Skip to content

T-20 increases tipranavir levels but does not increase risk of liver side-effects

Virologically failing NNRTI regimens have higher resistance risk than failing boosted-PIs

HIV prevention expenditure 'stagnant' in England

US guidance says that pregnant women should not take nelfinavir

Cognitive impairment common in people with HIV despite antiretroviral therapy

Onset of HIV dementia predicted by falling platelet count

First-line treatment choices proving challenging for African ART programmes

WHO to monitor ARV side-effects worldwide

Pillboxes should be standard issue for HIV patients, study concludes